ARMP - Armata Pharmaceuticals, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.16 0.29 (9.34%)	---	---	---	0.0 (0.0%)	0.29 (8.99%)	---	0.0 (0.0%)

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -0.45
Diluted EPS:: -0.45
Basic P/E:: -7.6778
Diluted P/E:: -7.6778
RSI(14) 1m:: 36.0
VWAP:: 3.44
RVol:: 2.7495

Events

Period	Kind	Movement	Occurred At
1m	Price increase 1m	3.46 +0.04 (+1.32%)	Oct 15 15:59
1m	Price decrease 1m	3.45 -0.05 (-1.43%)	Oct 15 15:38
Day	Price increase day	3.48 +0.32 (+10.13%)	Oct 15 15:32
Day	Rvol 2 increase day	rvol 2.06, 3.41 +0.25 (+7.91%)	Oct 15 15:22
1m	Price increase 1m	3.33 +0.04 (+1.06%)	Oct 15 14:44